Inventor · disambiguated record
Robert M. Jones
Also filed as: JONES ROBERT · JONES ROBERT M · JONES ROBERT MARK
70 granted patents·66 pending applications·591 citations·filing 1999–2024
99Inventor score
Top patents by PatentIndex Score
136 records- 0196US11771695B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Oct 3, 2023·4 cites·11 claims
- 0296US7884101B23-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Feb 8, 2011·42 cites·2 claims
- 0395US11124504B2Kappa opioid receptor antagonists and products and methods related theretoSCRIPPS RESEARCH INST·Filed 2020·Granted Sep 21, 2021·4 cites·81 claims
- 0494US11560369B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Jan 24, 2023·2 cites·20 claims
- 0594US8778950B2Cannabinoid receptor modulatorsJONES ROBERT M·Filed 2010·Granted Jul 15, 2014·21 cites·6 claims
- 0694US8580841B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersJONES ROBERT M·Filed 2009·Granted Nov 12, 2013·21 cites·51 claims
- 0794US8415484B2Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersJONES ROBERT M·Filed 2009·Granted Apr 9, 2013·29 cites·48 claims
- 0894US7838525B2Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Nov 23, 2010·39 cites·69 claims
- 0993US10981895B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2018·Granted Apr 20, 2021·4 cites·16 claims
- 1093US10183930B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 22, 2019·10 cites·11 claims
- 1193US9458136B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsBLACKBURN ANTHONY C·Filed 2012·Granted Oct 4, 2016·11 cites·34 claims
- 1293US9126932B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2013·Granted Sep 8, 2015·17 cites·61 claims
- 1393US7132426B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2004·Granted Nov 7, 2006·56 cites·57 claims
- 1492US11214548B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Granted Jan 4, 2022·3 cites·8 claims
- 1592US10676469B2Kappa opioid receptor antagonists and products and methods related theretoSCRIPPS RESEARCH INST·Filed 2018·Granted Jun 9, 2020·12 cites·59 claims
- 1692US10632134B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Granted Apr 28, 2020·5 cites·16 claims
- 1792US9522133B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2015·Granted Dec 20, 2016·9 cites·42 claims
- 1892US7115708B2β-Superfamily conotoxinsCOGNETIX INC·Filed 2005·Granted Oct 3, 2006·13 cites·20 claims
- 1991US9867822B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 16, 2018·7 cites·18 claims
- 2091US9492447B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2015·Granted Nov 15, 2016·9 cites·20 claims
- 2191US7470699B2Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2004·Granted Dec 30, 2008·41 cites·57 claims
- 2290US8785441B23-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2012·Granted Jul 22, 2014·11 cites·16 claims
- 2389US8362248B2Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Jan 29, 2013·10 cites·1 claims
- 2489US6767896B1Conotoxin peptidesCOGNETIX INC·Filed 2000·Granted Jul 27, 2004·32 cites·24 claims
- 2589US2025074874A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2024·Application pending·0 cites
- 2688US11897873B2Kappa opioid receptor antagonists and products and methods related theretoSCRIPPS RESEARCH INST·Filed 2021·Granted Feb 13, 2024·1 cites·6 claims
- 2788US9597340B2Cannabinoid receptor modulatorsTHATTE JAYANT·Filed 2012·Granted Mar 21, 2017·9 cites·17 claims
- 2888US7625906B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Dec 1, 2009·11 cites·50 claims
- 2987US7803753B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2006·Granted Sep 28, 2010·6 cites·11 claims
- 3086US8410119B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoJONES ROBERT M·Filed 2009·Granted Apr 2, 2013·8 cites·54 claims
- 3186US6797808B1α-conotoxin peptidesUNIV UTAH RES FOUND·Filed 2000·Granted Sep 28, 2004·16 cites·5 claims
- 3285US9108969B2Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2013·Granted Aug 18, 2015·6 cites·33 claims
- 3385US8198232B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelCHU ZHI-LIANG·Filed 2009·Granted Jun 12, 2012·5 cites·66 claims
- 3483US7666840B2α-Conotoxin peptidesUNIV UTAH RES FOUND·Filed 2007·Granted Feb 23, 2010·3 cites·5 claims
- 3582US9085581B2Processes for the preparation of S1P1 receptor modulators and crystalline forms thereofJONES ROBERT M·Filed 2011·Granted Jul 21, 2015·6 cites·30 claims
- 3682US7902153B2Alpha-conotoxin peptidesUNIV UTAH RES FOUND·Filed 2010·Granted Mar 8, 2011·3 cites·6 claims
- 3782US7816364B2GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating theretoARENA PHARM INC·Filed 2007·Granted Oct 19, 2010·4 cites·171 claims
- 3882US6855805B2α-conotoxin peptidesUNIV UTAH RES FOUND·Filed 2001·Granted Feb 15, 2005·15 cites·4 claims
- 3981US9944606B2Cannabinoid receptor modulatorsJONES ROBERT M·Filed 2012·Granted Apr 17, 2018·3 cites·30 claims
- 4081US8030270B2Methods for identifying GLP-1 secretagoguesARENA PHARM INC·Filed 2009·Granted Oct 4, 2011·2 cites·9 claims
- 4181US8022034B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2009·Granted Sep 20, 2011·2 cites·34 claims
- 4281US8003597B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2009·Granted Aug 23, 2011·2 cites·30 claims
- 4381US2023257349A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2022·Application pending·0 cites
- 4480US8101626B2GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating theretoCHU ZHI-LIANG·Filed 2010·Granted Jan 24, 2012·4 cites·38 claims
- 4580US7803754B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2006·Granted Sep 28, 2010·2 cites·24 claims
- 4679US7838254B2Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYYARENA PHARM INC·Filed 2009·Granted Nov 23, 2010·2 cites·27 claims
- 4778US8487075B2Alpha-conotoxin peptidesWATKINS MAREN·Filed 2012·Granted Jul 16, 2013·2 cites·4 claims
- 4878US8486646B2Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagoguesCHU ZHI-LIANG·Filed 2010·Granted Jul 16, 2013·3 cites·166 claims
- 4977US11534424B2Compounds and methods for treatment of primary biliary cholangitisARENA PHARM INC·Filed 2018·Granted Dec 27, 2022·3 cites·18 claims
- 5077US11186577B2Vasopressin receptor antagonists and products and methods related theretoBLACKTHORN THERAPEUTICS INC·Filed 2018·Granted Nov 30, 2021·2 cites·11 claims
Showing the top 50 of 136 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert M. Jones files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →